Hydrogel composite composition and hydrogel composite structure manufactured therefrom
The hydrogel composite structure addresses the limitations of conventional adipose tissue mimics by creating a multilayer design with amorphous particles and a matrix, enhancing mechanical resistance, viscoelasticity, and reducing adhesion, thus accurately simulating adipose tissue behavior.
Patent Information
- Application Number
- KR1020260131113
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2026-07-16
- Publication Date
- 2026-11-11
- Estimated Expiration
- 2046-07-16
AI Technical Summary
Conventional hydrogel-based adipose tissue mimics fail to accurately replicate the heterogeneous and hierarchical microstructure of adipose tissue, leading to issues with mechanical behavior, viscoelastic properties, and tactile feedback during surgical procedures, and often suffer from interfacial delamination and excessive adhesion.
A hydrogel composite structure is developed with a multilayer design, incorporating amorphous first hydrogel particles dispersed in a first matrix and a second matrix solution, utilizing biocompatible polymers and natural polymers with thermoreversible gelation properties to create a composite network that mimics the lobular structure and mechanical behavior of adipose tissue.
The composite structure provides stable mechanical resistance, viscoelastic feedback, and reduced surface adhesion, mimicking the behavior of actual adipose tissue during surgical simulations, with improved interfacial bonding and shape stability.
Smart Images

Figure 112026086775061-PAT00001_ABST
Abstract
Description
Technology Field
[0001] The present invention relates to a hydrogel composite composition and a hydrogel composite structure prepared therefrom. Background Technology
[0002] With the recent advancement of medical technology and the resulting increase in surgical precision, the importance of surgical simulation technology for acquiring surgical skills and training medical staff is growing. In particular, biomimetic structures capable of providing physical properties and tactile feedback similar to actual human tissue are widely used in the fields of surgical education, medical device performance evaluation, and the verification of new surgical techniques.
[0003] Such biomimetic structures must not merely reproduce the shape of human tissue but must also be capable of implementing mechanical behaviors similar to actual tissue during various surgical operations, such as incision, dissection, suturing, traction, and compression. In particular, adipose tissue performs not only energy storage functions within the human body but also a buffering function to protect internal organs from external shocks, existing in a complex combination with fascia, blood vessels, and connective tissue. Furthermore, adipose tissue forms a hierarchical structure in which multiple fat lobules are compartmentalized by connective tissue septa, exhibiting unique viscoelastic properties and tissue resistance during surgical procedures.
[0004] Therefore, structures designed to mimic adipose tissue need to go beyond the implementation of simple soft materials and reproduce the lobular microstructure of actual adipose tissue and the mechanical properties derived therefrom. In particular, it is important to similarly replicate the tissue deformation behavior, cutting resistance, tissue separation characteristics, and tactile feedback that occur during the incision and dissection process using surgical instruments such as scalpels, scissors, dissecting instruments, or electrocautery devices.
[0005] Meanwhile, conventional adipose tissue mimic materials are mainly manufactured using single hydrogel networks or uniform soft polymer materials. Although hydrogels are widely studied as soft tissue mimic materials based on their high water content and excellent biocompatibility, single network-based structures alone have limitations in sufficiently realizing the heterogeneous and hierarchical microstructure of actual adipose tissue.
[0006] In addition, conventional hydrogel-based fat mimics often have uniform physical properties throughout the entire tissue, making it difficult to reproduce local deformation characteristics or mechanical behavior at the interface between tissues that occur in actual fat tissue. As a result, there have been problems such as resistance different from actual biological tissue occurring during the incision or dissection process, or the shape retention of the cut surface and tissue separation behavior appearing differently from actual tissue.
[0007] In addition, some conventional technologies were developed with a focus on improving the strength of the structure or ensuring suture durability, which resulted in limitations in fully realizing the soft, flexible tactile sensation and viscoelastic properties characteristic of actual fat tissue. Conversely, if the strength of the structure is excessively reduced to improve the softness, problems may arise regarding shape retention or durability against repetitive surgical operations.
[0008] Therefore, there is a continuous demand for new hydrogel-based composite structures and compositions for implementing them that can mimic the lobular structure of actual adipose tissue while providing mechanical behavior, viscoelastic properties, and tactile feedback similar to actual tissue during the incision and dissection process. Prior art literature
[0009] Republic of Korea Open Public Notice No. 10-2021-0128971 (2021.10.27) Republic of Korea Open Public Notice No. 10-2018-0011656 (2018.02.02) The problem to be solved
[0010] The objective of the present invention is to provide a hydrogel composite composition that stably maintains mechanical behavior having a specific elastic range by implementing a multilayer structure in which a plurality of amorphous particles cross-linked with a biocompatible polymer are dispersed discontinuously within a matrix.
[0011] Another objective of the present invention is to provide a hydrogel composite structure capable of implementing unique viscoelastic feedback by controlling preferential fracture and deformation characteristics at the interface when external stress is applied, by using the composition to form a composite network structure in which physically separated particulate structures and a matrix connecting them are adjacent to each other. means of solving the problem
[0012] One embodiment of the present invention provides a hydrogel composite composition comprising: a plurality of amorphous first hydrogel particles comprising a first matrix comprising a biocompatible polymer and a first acrylamide-based crosslinking polymer and a plurality of biocompatible hydrogels in the form of spherical particles dispersed in the first matrix; and a second matrix solution comprising a second acrylamide-based monomer, a natural polymer having thermoreversible gelation properties and a polyalkylene glycol-based polymer, and disposed between the plurality of amorphous first hydrogel particles, wherein the plurality of amorphous first hydrogel particles are dispersed in a discontinuous phase within the second matrix solution.
[0013] The above-mentioned spherical particle-shaped biocompatible hydrogel may be formed by ionically crosslinking one or more natural polymers selected from the group consisting of alginate, chitosan, hyaluronic acid, pectin, and carrageenan by polyvalent cations.
[0014] The first monomer and the second acrylamide monomer for forming the first acrylamide-based crosslinked polymer may each independently comprise one or more selected from the group consisting of acrylamide, methacrylamide, N-isopropylacrylamide, N,N-dimethylacrylamide, and N-hydroxyethyl acrylamide.
[0015] The biocompatible polymer included in the first matrix and the natural polymer having thermoreversible gelation properties included in the second matrix solution may each independently include one or more selected from the group consisting of gelatin, agarose, collagen, elastin, and fibrin.
[0016] The above polyalkylene glycol-based polymer may include one or more selected from the group consisting of polyethylene glycol (PEG), polypropylene glycol (PPG), and polyethylene glycol-polypropylene glycol copolymer (PEG-PPG copolymer).
[0017] The above-mentioned amorphous first hydrogel particles may comprise fragments formed by physically fragmenting a primary hydrogel precursor in which the spherical particle-shaped biocompatible hydrogel is crosslinked in a state dispersed within the first matrix.
[0018] The hydrogel composite composition may comprise 50 to 200 parts by weight of the second matrix solution per 100 parts by weight of the amorphous first hydrogel particles.
[0019] The above-mentioned amorphous first hydrogel particles may be such that 50 to 300 parts by weight of the spherical particle-shaped biocompatible hydrogel are dispersed with respect to 100 parts by weight of the first matrix.
[0020] The second matrix solution may comprise 5 to 50 parts by weight of a natural polymer having thermoreversible gelling properties and 10 to 100 parts by weight of a polyalkylene glycol-based polymer, based on 100 parts by weight of the second acrylamide-based monomer.
[0021] The weight-average molecular weight (Mw) of the above polyalkylene glycol-based polymer may be 10,000 to 40,000 g / mol.
[0022] Another embodiment of the present invention provides a hydrogel composite structure comprising: a plurality of amorphous first hydrogel particles comprising a first matrix comprising a biocompatible polymer and a first acrylamide-based crosslinking polymer and a plurality of biocompatible hydrogels in the form of spherical particles dispersed in the first matrix; and a second hydrogel matrix comprising a second acrylamide-based crosslinking polymer, a natural polymer having thermoreversible gelation properties and a polyalkylene glycol-based polymer, and disposed between the plurality of amorphous first hydrogel particles, wherein the plurality of amorphous first hydrogel particles are discontinuous phases and are dispersed within the second hydrogel matrix which is a continuous phase.
[0023] The above-mentioned spherical particle-shaped biocompatible hydrogel may be dispersed within the first matrix to form a first dispersed phase, and the amorphous first hydrogel particles containing the first dispersed phase may be dispersed within the second hydrogel matrix to form a second dispersed phase, and may include a multilayer dispersion structure.
[0024] The above-mentioned spherical particle-shaped biocompatible hydrogel includes an ionic crosslinking structure formed by multivalent cations, and the first matrix and the second hydrogel matrix may each include a crosslinking structure formed by an acrylamide-based crosslinking polymer.
[0025] The plurality of amorphous first hydrogel particles include a fracture surface formed by fragmentation, and at least a portion of the fracture surface may include an area where the spherical particle-shaped biocompatible hydrogel and the first matrix are exposed to the outside together and come into contact with the second hydrogel matrix. Effects of the invention
[0026] According to the present invention, a hydrogel composite composition and a structure produced therefrom comprise a multilayer structure in which a plurality of amorphous hydrogel particles, cross-linked in a first matrix, are dispersed discontinuously within a second matrix comprising agarose and a polyalkylene glycol-based polymer. Thus, the hydrogel composite structure produced by curing the composition not only physically mimics the lobular microstructure of actual human adipose tissue but also exhibits significantly lower ultra-low elasticity viscoelastic behavior compared to conventional structures, thereby providing the effect of securing mechanical resistance at the same level as removing actual biological adipose tissue when tissue incision and dissection using a scalpel, etc., during surgical simulation.
[0027] In addition, interfacial separation or delamination between the dispersed phase and the continuous phase, which may occur when the content of the acrylamide-based cross-linked polymer is reduced to achieve viscoelasticity at the level of biological soft tissue, can be effectively prevented. Specifically, by forming a composite network structure in which the second hydrogel matrix is adjacent to and mutually infiltrated with the fracture surface of the amorphous first hydrogel particles formed through the fragmentation process, interfacial bonding strength can be improved and the integrity and shape stability of the structure against external forces can be secured.
[0028] In addition, the polyalkylene glycol-based polymer included in the second hydrogel matrix functions as a plasticizing component within the composite network, thereby suppressing excessive adhesion characteristics on the surface of the structure. Accordingly, during surgical simulations, surface adhesion with instruments is minimized not only with general surgical instruments but also in environments where energy-using surgical equipment, such as electrocautery devices, is applied, thereby providing the same level of maneuverability and usability as actual biological tissue. Brief explanation of the drawing
[0029] FIG. 1 relates to an image of fracture behavior in which a multilayer structure composed of amorphous particles and a matrix tears or peels off similarly to actual biological adipose tissue when an external force is applied to a hydrogel composite structure manufactured according to one embodiment of the present invention. FIG. 2 relates to step-by-step images of a process for manufacturing a spherical particle-shaped biocompatible hydrogel (bead) during the process of manufacturing a hydrogel composite composition according to one embodiment of the present invention. FIG. 3 is an image showing the monomer diffusion induction and filtration process through soaking of spherical biocompatible hydrogel particles in a first matrix solution according to one embodiment of the present invention. FIG. 4 is an image showing the process (a, b) of a mixture of spherical hydrogel particles immersed in a mold and a first matrix solution being cured to form a first matrix structure according to one embodiment of the present invention, and the molded appearance (c) of a final hydrogel composite structure formed by fragmenting the structure and compounding it with a second matrix solution. FIG. 5 is a schematic cross-sectional view of a multilayer composite structure for surgical simulation in which a hydrogel composite structure according to one embodiment of the present invention is stacked in a plurality of layers and a hollow tubular structure is disposed inside. FIGS. 6 and 7 are images showing a process of sequentially stacking and molding a multilayer organ model for surgical simulation, in which a plurality of tubular structures are embedded inside, within a mold using a hydrogel composite structure according to one embodiment of the present invention. FIG. 8 is a graph showing a comparison of the storage modulus and loss modulus according to the shear strain of a hydrogel composite structure and actual biological adipose tissue according to one embodiment and a comparative example of the present invention. FIG. 9 is a schematic diagram showing a comparison of the shape stability and internal material leakage inhibition patterns of conventional single-material-based biocompatible hydrogel particles and composite-material-based biocompatible hydrogel particles according to one embodiment of the present invention. Figure 10 is a schematic diagram and photograph showing interfacial delamination defects between particles and the matrix that occur when a conventional single bulk molding process is applied with a reduced content of the matrix precursor to achieve ultra-low elasticity similar to biological tissue. FIG. 11 is a schematic diagram and photograph showing the manufacturing process and appearance of a hydrogel composite structure in which structural integrity and interaction between particles and a matrix are formed by applying primary curing, fragmentation, and secondary immersion processes according to one embodiment of the present invention. Specific details for implementing the invention
[0030] Embodiments of the present invention will be described in detail below. Prior to this, terms and words used in this specification and claims should not be interpreted as being limited to their ordinary or dictionary meanings. Instead, based on the principle that the inventor can appropriately define the concepts of terms to best describe their invention, they should be interpreted in a meaning and concept consistent with the technical spirit of the present invention. Therefore, the configurations described in the embodiments of this specification are merely one preferred embodiment of the present invention and do not represent all aspects of the technical spirit of the present invention. It should be understood that various equivalents and modifications capable of replacing them may exist at the time of filing this application.
[0031] Throughout this specification, when a part is described as "comprising" a certain component, this means that, unless specifically stated otherwise, it does not exclude other components but may include additional components.
[0032] Furthermore, descriptions that specify components by limiting or adding them may be applied to all inventions unless there are special limitations, and are not limited to specific inventions.
[0033] In addition, throughout the description of the invention and claims of this application, items indicated in the singular include cases where they are plural unless otherwise noted.
[0034] In addition, throughout the description of the invention and the claims of the present invention, "or" includes "and" unless otherwise noted. Therefore, "comprising A or B" means all three of the above cases: including A, including B, or including both A and B.
[0035] In addition, all numerical ranges include the values at both ends and all intermediate values in between, unless explicitly stated to be excluded.
[0036] As used in this specification, "fragmentation" is not limited to mechanical cutting or grinding processes using specific equipment, and may be used to include all forms of processing processes that divide a hydrogel structure or hydrogel precursor into multiple pieces by applying physical stress.
[0037] Additionally, as used in this specification, "atypical" means a shape that does not have a regularly defined geometric shape, such as a sphere, ellipsoid, polyhedron, etc., and may include, as an example, a particle shape having an irregular fracture surface, a curved surface, or a non-uniform outer shape.
[0038] The terms “curing” or “crosslinking” as used in this specification are not limited to the formation of covalent bonds by chemical crosslinking agents, but may be used to include the formation of ionic bonds by multivalent ions, physical gelation of thermoreversible polymers, entanglement between polymer chains, or similar interactions, in which a composition loses fluidity and maintains a certain shape through a process of forming a physical or chemical structure.
[0039] As used herein, "continuous phase" refers to a phase that is continuously connected to form a matrix within a composition or composite, and "discontinuous phase" refers to a particulate or fragmentary structure that is dispersed within the continuous phase and has individual boundaries.
[0040] As used herein, "immersion" refers to a process of bringing an object into contact with a solution, which may include a process in which a component contained in the solution diffuses or penetrates into the surface or interior of the object due to a concentration gradient. In one embodiment, the immersion may include a process in which a monomer, a crosslinking agent, or other solute penetrates into the internal pores or network structure of the object to participate in a subsequent reaction or structure formation.
[0042] Hydrogel composite composition
[0043] The present invention relates to a hydrogel composite composition and a hydrogel composite structure using the same, and more specifically, to a hydrogel composite composition with a multilayer structure for realizing the structural characteristics and physical behavior of adipose tissue and a tissue mimic comprising the same.
[0044] Specifically, the hydrogel composite composition of the present invention comprises: a plurality of amorphous first hydrogel particles comprising a first matrix comprising a biocompatible polymer and a first acrylamide-based crosslinking polymer and a spherical biocompatible hydrogel dispersed in the first matrix; and a second matrix solution comprising a second acrylamide-based monomer, a natural polymer having thermoreversible gelation properties, and a polyalkylene glycol-based polymer, disposed between the plurality of amorphous first hydrogel particles. In this case, the plurality of amorphous first hydrogel particles have a structure in which they are dispersed in a discontinuous phase within the second matrix solution. Such a dual-phase dispersion structure consisting of a continuous phase and a discontinuous phase can realize interfacial rupture and exfoliation behaviors that are difficult to achieve in conventional single homogeneous hydrogel structures, and can provide structural features that mimic tissue behaviors occurring during the process of tissue incision and exfoliation by surgical instruments.
[0045] In one embodiment of the present invention, the spherical particle-shaped biocompatible hydrogel may be formed by ionically crosslinking one or more natural polymers selected from the group consisting of alginate, chitosan, hyaluronic acid, pectin, and carrageenan by polyvalent cations.
[0046] FIG. 9 is a schematic diagram showing a comparison of the shape stability and internal material leakage inhibition patterns of conventional single-material-based biocompatible hydrogel particles and composite-material-based biocompatible hydrogel particles according to one embodiment of the present invention.
[0047] Referring to FIG. 9, when hydrogel particles are manufactured using only a single material such as alginate as in the prior art, in order to realize relatively large spherical particles of a size of 2 to 5 mm, which is the average size of lobules of actual human adipose tissue, unreacted liquid components (e.g., aqueous calcium chloride solution) remaining inside the particles may leak out of the particles over time. Consequently, the shape of the particles may be deformed or shape stability may be reduced.
[0048] To improve this, a mixed solution for forming a biocompatible hydrogel according to one embodiment of the present invention may further include a natural polymer (e.g., agarose) having thermoreversible gelation properties and an acrylamide-based monomer. The composite material-based hydrogel particles prepared from the mixed solution can maintain a spherical shape as the leakage of unreacted solution inside the large particles is suppressed by the thermoreversible gelation structure. In addition, the included acrylamide-based monomer can form a polymerization reaction with the matrix component in a subsequent process to improve the interfacial bonding strength between the particles and the matrix.
[0049] As an example of a specific manufacturing process for the above-mentioned spherical particle-shaped biocompatible hydrogel, a mixed solution containing the above-mentioned natural polymer may be heated and dissolved, and then introduced in the form of droplets into an aqueous crosslinking agent solution containing polyvalent cations (e.g., an aqueous calcium chloride solution) to induce an ionic crosslinking reaction, thereby forming spherical biocompatible hydrogel beads. At this time, the aqueous crosslinking agent solution may be stirred at a predetermined stirring speed (e.g., 100 to 300 rpm) to suppress the aggregation of the particles being formed and to maintain a spherical shape. In addition, the distance between the droplet injection nozzle and the surface of the aqueous crosslinking agent solution may be controlled to a predetermined range (e.g., 1 to 10 cm) so that a stable sphere can be formed before the droplets reach the aqueous crosslinking agent solution.
[0050] The spherical particle-shaped biocompatible hydrogel formed as described above is dispersed within the first matrix described later to form a composite structure and can act as a dispersed phase that disperses stress when an external force is applied. This stress dispersion effect may be attributed to the physical properties of the spherical particle-shaped biocompatible hydrogel, which possesses relatively higher mechanical strength compared to the first and second matrices described later. Specifically, when a suturing procedure is performed after the hydrogel composite composition has hardened, the spherical particles can act as mechanical supports along the path of the suture even if the surgical suture penetrates the hardened body of the composition and generates tension. Accordingly, fracture or damage that may occur due to stress concentration in the relatively ductile matrix region can be suppressed, and consequently, excellent suture retention can be achieved.
[0051] In one embodiment, the mixed solution for preparing the biocompatible hydrogel in the form of spherical particles may further include a coloring agent. The coloring agent may be a pigment or dye that produces a color similar to that of biological tissue. Accordingly, the spherical particles can be visually distinguished from the matrix component surrounding them, and a heterogeneous structure similar to an adipose tissue lobule can be visually realized when a cross-section of the composite structure is cut and exposed during a surgical simulation. Thus, visual characteristics similar to the cross-section of actual adipose tissue can be provided.
[0052] Additionally, the biocompatible hydrogel in the form of spherical particles formed in the above-mentioned crosslinking agent aqueous solution may contain a residual aqueous solution of polyvalent cations that did not participate in ion crosslinking in the internal and surface pores. The residual aqueous solution may be exchanged with the monomer components in the first matrix solution by diffusion according to a concentration gradient during a subsequent mixing or immersion process with the first matrix solution. Accordingly, the first matrix components may penetrate into the surface and interior of the spherical particles to form an interfacial diffusion layer, and consequently, the spherical particles may function as a structural support to enhance interfacial bonding within the composite structure.
[0053] In one embodiment of the present invention, the first monomer and the second acrylamide monomer for forming the first acrylamide-based crosslinking polymer may each independently include one or more selected from the group consisting of acrylamide, methacrylamide, N-isopropylacrylamide, N,N-dimethylacrylamide, and N-hydroxyethyl acrylamide. The acrylamide monomer may be polymerized to form a crosslinking polymer network that forms the framework of a hydrogel composite structure.
[0054] The above-mentioned cross-linked polymer network can stably maintain moisture and dispersed phases within the matrix due to its hydrophilic properties, and can perform the role of providing elastic restoring force to maintain the shape of the structure even when compressive or tensile force is applied from the outside.
[0055] In particular, by using a material having the same or similar chemical structure as the first acrylamide-based monomer constituting the first matrix and the second acrylamide-based monomer constituting the second matrix solution, the chemical compatibility between the amorphous first hydrogel particles and the second hydrogel matrix can be improved. Accordingly, during the process in which the second matrix solution is injected and cured after the fragmentation process, interfacial bonding between the polymer chains or residual reactive sites present on the exposed surface of the amorphous first hydrogel particles and the monomers in the second matrix solution can be promoted. Additionally, polymer chain entanglement between the two networks can be formed, thereby improving the interfacial adhesion between the particles and the matrix.
[0056] As a result, the amorphous first hydrogel particles can be structurally bonded through the interface beyond simply being dispersed within the second hydrogel matrix, and thus contribute to maintaining the integrity of the structure even when an external shear force is applied. In addition, the occurrence of interfacial separation or macroscopic layer separation between the particles and the matrix can be suppressed.
[0057] Meanwhile, the chemical crosslinking network formed by the acrylamide-based crosslinking polymer can form a structure that interpenetrates with the physical network formed by the natural polymer having the thermoreversible gelation properties described later. Accordingly, structural stability due to the chemical crosslinking network and deformation compliance due to the physical network can be expressed in combination, and as a result, the mechanical properties and durability of the hydrogel composite structure can be improved.
[0058] In one embodiment of the present invention, the biocompatible polymer included in the first matrix and the natural polymer having thermoreversible gelation characteristics included in the second matrix solution may each independently include one or more selected from the group consisting of gelatin, agarose, collagen, elastin, and fibrin. The natural polymer may have thermoreversible gelation characteristics in response to temperature changes. Accordingly, when heated, it exists in a fluid solution state to facilitate mixing with monomers and amorphous first hydrogel particles, and when cooled, it forms a physical gelation network to maintain the shape of the composite composition until subsequent chemical curing is completed.
[0059] The physical gelation network described above can suppress sedimentation or local aggregation of amorphous first hydrogel particles dispersed in the mixed solution prior to curing. Specifically, the physical gelation structure formed by cooling can improve the stability of the dispersion structure during the chemical crosslinking reaction by maintaining the amorphous first hydrogel particles in a dispersed state in three-dimensional space. Accordingly, a structure in which the amorphous first hydrogel particles are more uniformly distributed throughout the final cured body can be realized regardless of the shape or size of the molded body.
[0060] In addition, the natural polymer having the above-mentioned thermoreversible gelation properties can be distributed within and between the spaces of the chemical crosslinking network formed by the polymerization of the acrylamide-based monomer to form a semi-interpenetrating polymer network structure. This structure provides a form in which the chemical crosslinking network and the physical gelation network exist in combination, thereby allowing control of the mechanical properties and deformation behavior of the hydrogel composite structure.
[0061] In one embodiment, when local shear stress is applied from the outside, the physical bonds formed by the natural polymer can be dissociated relatively easily compared to chemical covalent bonds. Accordingly, some of the energy from the external force can be dissipated during the dissociation of the physical bonds, and the structure can exhibit behavior that conforms to local deformation. This composite structure of physical and chemical networks can contribute to realizing mechanical response characteristics similar to biological tissue during incision or deformation.
[0062] In one embodiment of the present invention, the polyalkylene glycol-based polymer may include one or more selected from the group consisting of polyethylene glycol (PEG), polypropylene glycol (PPG), and polyethylene glycol-polypropylene glycol copolymer (PEG-PPG copolymer). The polyalkylene glycol-based polymer may not directly participate in or may participate in a crosslinking reaction in a limited manner, while forming physical entanglements between polymer chains and functioning as a plasticizing component within the matrix.
[0063] Generally, when the content of acrylamide monomers is reduced to achieve mechanical properties similar to actual biological soft tissue, there is a problem of increased stickiness on the hydrogel surface. The polyalkylene glycol-based polymer acts as a plasticizing component within the composite network to mitigate these surface adhesion characteristics. Accordingly, when tissue is manually manipulated or comes into contact with robotic surgical instruments and electrocautery devices during surgical simulation, surface adhesion phenomena can be suppressed, thereby providing manipulability and usability similar to actual tissue.
[0064] Specifically, the polyalkylene glycol-based polymer can control the interaction between polymer chains by being distributed within a three-dimensional network structure formed by the acrylamide-based monomer and the thermoreversible natural polymer. Accordingly, direct contact between polymer chains and the formation of hydrogen bonds can be mitigated, and the elastic properties and viscoelastic behavior of the composite matrix can be controlled.
[0065] In addition, the storage modulus of the composite matrix can be reduced by introducing the above-mentioned polyalkylene glycol-based polymer, thereby enabling the realization of mechanical properties similar to soft tissues. In particular, it can exhibit higher deformation compliance when compressive, tensile, or shear forces are applied, and can contribute to the realization of biological tissue-like properties.
[0066] In addition, the present invention is characterized by selectively including a polyalkylene glycol-based polymer instead of inorganic additives such as silica (SiO2) or zinc oxide (ZnO) to reduce the surface tackiness of a hydrogel composite structure. While the use of inorganic additives may partially improve surface tackiness, the mechanical stiffness of the structure increases, which may limit the realization of the soft properties inherent to adipose tissue. Furthermore, in the case of zinc oxide, there is a possibility of causing color change or reduced shape stability, which may limit its application to tissue mimics. In contrast, the polyalkylene glycol-based polymer according to the present invention can effectively reduce surface tackiness without excessively increasing the mechanical stiffness of the structure.
[0067] In one embodiment, the weight-average molecular weight (Mw) of the polyalkylene glycol-based polymer may be 10,000 to 40,000 g / mol, preferably 15,000 to 30,000 g / mol, and more preferably 15,000 to 25,000 g / mol. If the weight-average molecular weight is less than 10,000 g / mol, a relatively large amount of addition may be required to secure the desired level of surface tackiness reduction effect, and in this case, a decrease in shape stability may occur due to an increase in the water content of the structure. On the other hand, if the weight-average molecular weight exceeds 40,000 g / mol, the viscosity of the composition may increase, which may reduce mixability, injectability, or moldability, and due to the steric influence of the polymer chain, compatibility with other components may decrease, and there is a possibility that phase separation may occur during the curing process.
[0068] Accordingly, in order to secure a balance of surface tackiness reduction effect, soft physical properties, and shape stability, it is preferable that the weight-average molecular weight of the polyalkylene glycol-based polymer be about 15,000 g / mol to 25,000 g / mol.
[0069] In addition, the polyalkylene glycol-based polymer may be included in an amount of 1.5 to 3.0 wt% based on the total weight of the entire hydrogel composite composition, preferably in an amount of about 2.0 wt%. If the content is less than 1.5 wt%, the effect of reducing surface tackiness may not be sufficient, and if it exceeds 3.0 wt%, the mechanical stiffness of the structure may be reduced or the shape stability may be decreased. When satisfying the above molecular weight and content ranges, the polyalkylene glycol-based polymer can effectively reduce surface tackiness while maintaining the mechanical properties and shape stability of the structure with only a small amount of addition.
[0070] In one embodiment of the present invention, the amorphous first hydrogel particles may include fragments formed by physically fragmenting a primary hydrogel precursor in which the spherical particle-shaped biocompatible hydrogel is crosslinked in a state dispersed within the first matrix.
[0071] In order to achieve the ultra-low elasticity characteristic of biological soft tissues, the monomer content within the matrix is reduced. Consequently, the bonding force between the first matrix and the spherical particles is lowered, which may lead to interfacial delamination. The fragmentation process is introduced to address this issue. By crushing the primary cured precursor and performing a subsequent immersion process, a coating structure can be formed in which the second matrix surrounds the spherical particles. This enhances the interaction between the discontinuous and continuous phases and suppresses interfacial delamination, thereby improving the shape stability of the final structure.
[0072] The above-mentioned amorphous first hydrogel particles are particulate structures formed, for example, through a mechanical crushing process, and may have irregular shapes and surface structures instead of regular shapes such as spherical or elliptical. Specifically, the above-mentioned amorphous first hydrogel particles may include polyhedral surface irregularities and irregular fracture surfaces, which may be structural features formed during the mechanical crushing process.
[0073] Additionally, the amorphous first hydrogel particles may include an interfacial region formed between an internal spherical particle-shaped biocompatible hydrogel and an external first matrix. In one embodiment, the interfacial region may be formed as a monomer component included in the first matrix diffuses into the surface and internal pores of the spherical particles during the immersion process. Subsequently, during the curing process, the monomer component forms a polymer network, thereby forming an interfacial bond between the spherical particles and the first matrix. Accordingly, the amorphous first hydrogel particles may have a composite structure in which the spherical particles and the first matrix are structurally bonded, and separation or detachment between the components may be suppressed even when an external force is applied.
[0074] Additionally, the amorphous first hydrogel particles may include a fracture surface formed during the crushing process, and at least a portion of the fracture surface may expose a biocompatible hydrogel in the form of spherical particles or an interfacial region formed between the spherical particles and the first matrix. This exposed structure facilitates contact with a second matrix introduced in a subsequent process and can provide favorable conditions for the formation of interfacial bonding between the amorphous first hydrogel particles and the second matrix.
[0075] The above-mentioned amorphous first hydrogel particles can be dispersed in a discontinuous phase within the final composition, and the second matrix filling between the particles can form a continuous phase. Accordingly, the final hydrogel composite structure can have a structure in which the discontinuous phase and the continuous phase are distributed in combination, and can realize a form similar to the structural characteristics of biological tissue.
[0076] In addition, the above-described structure may exhibit deformation and fracture behaviors different from those of a homogeneous hydrogel when external forces, such as incision, peeling, or compression, are applied. For example, deformation or fracture may occur mainly in the second matrix region between the amorphous first hydrogel particles, thereby enabling mechanical response characteristics similar to those of biological tissue.
[0077] In one embodiment of the present invention, the hydrogel composite composition may include a composite dispersion structure in which a plurality of phases are arranged in different hierarchical structures. Specifically, the hydrogel composite composition may include a first amorphous hydrogel particle comprising a first matrix in which a biocompatible hydrogel in the form of spherical particles is dispersed, and a second matrix filling the space between the first amorphous hydrogel particles.
[0078] The first matrix may include a biocompatible hydrogel in the form of spherical particles within a three-dimensional polymer network, and accordingly, an amorphous first hydrogel particle of a composite structure in which the spherical particles and the first matrix are combined may be formed.
[0079] The plurality of amorphous first hydrogel particles can form a discontinuous phase existing in a separated state within the composition. On the other hand, the second matrix can form a continuous phase by filling the space between the amorphous first hydrogel particles. Accordingly, the final composition may have a dual-phase structure in which a discontinuous phase and a continuous phase coexist.
[0080] In the above structure, the discontinuous phase amorphous first hydrogel particles and the continuous phase second matrix may have different mechanical properties. Therefore, when an external force such as cutting, compression, tension, or shear is applied, stress may be concentrated near the interface between the two phases, and accordingly, deformation or fracture behavior different from that of a homogeneous hydrogel may be exhibited.
[0081] For example, deformation or destruction of the structure may occur preferentially in the second matrix region or interface region located between the particles rather than in the amorphous first hydrogel particles themselves. Accordingly, deformation behavior similar to the structural characteristics of biological tissue can be realized, and usability as a tissue mimic for surgical simulation can be improved.
[0082] In addition, the amorphous first hydrogel particles can function as structural reinforcements dispersed within the continuous phase. Accordingly, even if local cracks occur in the second matrix region, the crack propagation path can be changed or restricted, and as a result, the shape stability and durability of the structure can be improved.
[0083] Meanwhile, the first matrix and the second matrix may include identical or similar acrylamide-based polymer networks. Accordingly, mutual penetration or entanglement between polymer chains may be formed at the interface of the two phases, and interfacial adhesion between the amorphous first hydrogel particles and the second matrix may be enhanced. As a result, the amorphous first hydrogel particles are not easily separated from the continuous phase, while the entire structure may exhibit unique mechanical behavior due to a composite structure in which discontinuous and continuous phases coexist.
[0084] In one embodiment of the present invention, the hydrogel composite composition may comprise 50 to 200 parts by weight of the second matrix solution per 100 parts by weight of the amorphous first hydrogel particles. For example, the hydrogel composite composition may comprise the second matrix solution in an amount of 50 parts by weight or more, 55 parts by weight or more, 60 parts by weight or more, 65 parts by weight or more, 70 parts by weight or more, 75 parts by weight or more, 80 parts by weight or more, 85 parts by weight or more, 90 parts by weight or more, 95 parts by weight or more, 100 parts by weight or more, 105 parts by weight or more, 110 parts by weight or more, 115 parts by weight or more, 120 parts by weight or more, or 125 parts by weight or more, with respect to 100 parts by weight of the amorphous first hydrogel particles, and 200 parts by weight or less, 195 parts by weight or less, 190 parts by weight or less, 185 parts by weight or less, 180 parts by weight or less, 175 parts by weight or less, 170 parts by weight or less, 165 parts by weight or less, 160 parts by weight or less, 155 parts by weight or less, 150 parts by weight or less, It may contain 145 parts by weight or less, 140 parts by weight or less, 135 parts by weight or less, or 130 parts by weight or less.
[0085] The relative content of the amorphous first hydrogel particles and the second matrix solution may affect the distribution and volume ratio of the discontinuous phase and the continuous phase within the final structure. When the content of the above components in the composition falls within the above range, the amorphous first hydrogel particles may exist in a dispersed state within the second matrix solution, and subsequently, through a curing process, a structure in which the discontinuous phase and the continuous phase are complexly distributed may be formed.
[0086] In addition, the second matrix solution can fill the space between the amorphous first hydrogel particles and can form a continuous phase by contacting the surface and fracture surface of the amorphous first hydrogel particles. Accordingly, interfacial bonding between the amorphous first hydrogel particles and the second matrix can be improved, and the integrity of the final structure can be improved.
[0087] If the content of the second matrix solution is less than 50 parts by weight relative to 100 parts by weight of the amorphous first hydrogel particles, it may not be able to sufficiently fill the space between the amorphous first hydrogel particles. Consequently, voids may be formed inside the structure or an uneven structure may be formed, and as a result, the mechanical properties and shape stability of the structure may be reduced.
[0088] On the other hand, if the content of the second matrix solution exceeds 200 parts by weight relative to 100 parts by weight of the amorphous first hydrogel particles, the proportion of the continuous phase in the composition may increase and the distribution density of the discontinuous phase may decrease. Accordingly, the influence of the discontinuous phase structure formed by the amorphous first hydrogel particles may be reduced, and the deformation and fracture behavior of the structure may approach the characteristics of a more homogeneous hydrogel.
[0089] In one embodiment of the present invention, the amorphous first hydrogel particles may comprise 50 to 300 parts by weight of the spherical particle-shaped biocompatible hydrogel with respect to 100 parts by weight of the first matrix. For example, the amorphous first hydrogel particles may comprise the spherical particle-shaped biocompatible hydrogel in an amount of 50 parts by weight or more, 55 parts by weight or more, 60 parts by weight or more, 65 parts by weight or more, 70 parts by weight or more, 75 parts by weight or more, 80 parts by weight or more, 85 parts by weight or more, 90 parts by weight or more, 95 parts by weight or more, 100 parts by weight or more, 105 parts by weight or more, 110 parts by weight or more, 115 parts by weight or more, 120 parts by weight or more, 125 parts by weight or more, 130 parts by weight or more, 135 parts by weight or more, 140 parts by weight or more, 145 parts by weight or more, 150 parts by weight or more, 155 parts by weight or more, 160 parts by weight or more, 165 parts by weight or more, 170 parts by weight or more, or 175 parts by weight or more, with respect to 100 parts by weight of the first matrix, and 300 parts by weight It may contain 295 parts by weight or less, 290 parts by weight or less, 285 parts by weight or less, 280 parts by weight or less, 275 parts by weight or less, 270 parts by weight or less, 265 parts by weight or less, 260 parts by weight or less, 255 parts by weight or less, 250 parts by weight or less, 245 parts by weight or less, 240 parts by weight or less, 235 parts by weight or less, 230 parts by weight or less, 225 parts by weight or less, 220 parts by weight or less, 215 parts by weight or less, 210 parts by weight or less, 205 parts by weight or less, 200 parts by weight or less, 195 parts by weight or less, 190 parts by weight or less, 185 parts by weight or less, or 180 parts by weight or less.
[0090] The relative content of the spherical particle-shaped biocompatible hydrogel and the first matrix may affect the internal structure and mechanical properties of the amorphous first hydrogel particles. Specifically, the spherical particle-shaped biocompatible hydrogel may exist in a dispersed state within the first matrix and form the structural framework of the amorphous first hydrogel particles, and the first matrix may form a continuous phase that surrounds and binds the spherical particles.
[0091] If the content of the above-mentioned biocompatible hydrogel in the form of spherical particles is less than 50 parts by weight relative to 100 parts by weight of the first matrix, the distribution density of the spherical particles within the amorphous first hydrogel particles may decrease. Consequently, the structural reinforcement effect provided by the spherical particles may not be sufficiently expressed, and the mechanical properties of the amorphous first hydrogel particles may be determined primarily by the properties of the first matrix. Additionally, amorphous particles of the desired shape may not be formed during the crushing process, or the shape stability of the particles may be reduced.
[0092] On the other hand, if the content of the spherical particle-shaped biocompatible hydrogel exceeds 300 parts by weight relative to 100 parts by weight of the first matrix, the relative content of the first matrix binding the spherical particles may decrease. Accordingly, the internal binding force of the amorphous first hydrogel particles may be reduced, and excessively small fragments may be formed or the particle shape may become non-uniform during the crushing process.
[0093] In addition, if the content of the first matrix is excessively reduced, the region contributing to the formation of interfacial bonding with the second matrix in subsequent processes may be reduced. Accordingly, the interfacial adhesion between the amorphous first hydrogel particles and the second matrix may be reduced, and the integrity and shape stability of the final structure may be reduced.
[0094] Accordingly, by including 50 to 300 parts by weight of spherical particle-shaped biocompatible hydrogel with respect to 100 parts by weight of the first matrix, structural stability of the amorphous first hydrogel particles can be secured, and the formation of amorphous particles through a crushing process can be stably realized. In addition, by appropriately maintaining interfacial bonding characteristics with the second matrix in a subsequent process, the integrity and shape stability of the final structure can be improved.
[0095] In one embodiment of the present invention, the second matrix solution may comprise 5 to 50 parts by weight of a natural polymer having thermoreversible gelling properties and 10 to 100 parts by weight of a polyalkylene glycol-based polymer, based on 100 parts by weight of the second acrylamide-based monomer.
[0096] For example, the second matrix solution may contain, based on 100 parts by weight of the second acrylamide-based monomer, a natural polymer having thermoreversible gelling properties in an amount of 5 parts by weight or more, 6 parts by weight or more, 7 parts by weight or more, 8 parts by weight or more, 9 parts by weight or more, 10 parts by weight or more, 11 parts by weight or more, 12 parts by weight or more, 13 parts by weight or more, 14 parts by weight or more, 15 parts by weight or more, 16 parts by weight or more, 17 parts by weight or more, 18 parts by weight or more, 19 parts by weight or more, 20 parts by weight or more, 21 parts by weight or more, 22 parts by weight or more, or 23 parts by weight or more, and "50 parts by weight or less, 49 parts by weight or less, 48 parts by weight or less, 47 parts by weight or less, 46 parts by weight or less, 45 parts by weight or less, 44 parts by weight or less, 43 parts by weight or less, 42 parts by weight or less, 41 parts by weight or less, 40 parts by weight It may contain 39 parts by weight or less, 38 parts by weight or less, 37 parts by weight or less, 36 parts by weight or less, 35 parts by weight or less, 34 parts by weight or less, 33 parts by weight or less, 32 parts by weight or less, 31 parts by weight or less, 30 parts by weight or less, 29 parts by weight or less, 28 parts by weight or less, 27 parts by weight or less, 26 parts by weight or less, 25 parts by weight or less, or 24 parts by weight or less.
[0097] For example, based on 100 parts by weight of the second acrylamide-based monomer, the second matrix solution comprises 10 parts by weight or more, 11 parts by weight or more, 12 parts by weight or more, 13 parts by weight or more, 14 parts by weight or more, 15 parts by weight or more, 16 parts by weight or more, 17 parts by weight or more, 18 parts by weight or more, 19 parts by weight or more, 20 parts by weight or more, 21 parts by weight or more, 22 parts by weight or more, 23 parts by weight or more, 24 parts by weight or more, 25 parts by weight or more, 26 parts by weight or more, 27 parts by weight or more, 28 parts by weight or more, 29 parts by weight or more, 30 parts by weight or more, 31 parts by weight or more, 32 parts by weight or more, 33 parts by weight or more, 34 parts by weight or more, 35 parts by weight or more, 36 parts by weight or more, 37 parts by weight or more, 38 parts by weight or more, 39 parts by weight or more, It may include 40 parts by weight or more, 41 parts by weight or more, 42 parts by weight or more, 43 parts by weight or more, 44 parts by weight or more, 45 parts by weight or more, 46 parts by weight or more, 47 parts by weight or more, 48 parts by weight or more, 49 parts by weight or more, 50 parts by weight or more, 51 parts by weight or more, 52 parts by weight or more, 53 parts by weight or more, 54 parts by weight or more, or 55 parts by weight or more, and may include 100 parts by weight or less, 99 parts by weight or less, 98 parts by weight or less, 97 parts by weight or less, 96 parts by weight or less, 95 parts by weight or less, 94 parts by weight or less, 93 parts by weight or less, 92 parts by weight or less, 91 parts by weight or less, 90 parts by weight or less, 89 parts by weight or less, 88 parts by weight or less, 87 parts by weight or less, 86 parts by weight or less, 85 parts by weight or less, 84 parts by weight or less, 83 parts by weight or less, 82 parts by weight or less, 81 parts by weight or less, 80 parts by weight or less, 79 parts by weight or less, 78 parts by weight or less, 77 parts by weight or less, 76 parts by weight or less, 75 parts by weight or less, 74 parts by weight or less, 73 parts by weight or less, 72 parts by weight or less, 71 parts by weight or less, 70 parts by weight or less, 69 parts by weight or less, 68 parts by weight or less, 67 parts by weight or less, 66 parts by weight or less, 65 parts by weight or less, 64 parts by weight or less,It may contain 63 parts by weight or less, 62 parts by weight or less, 61 parts by weight or less, 60 parts by weight or less, 59 parts by weight or less, 58 parts by weight or less, 57 parts by weight or less, or 56 parts by weight or less.
[0098] The content of the above natural polymer and polyalkylene glycol-based polymer may affect the flow characteristics of the second matrix, particle dispersion stability before curing, and mechanical properties of the final cured body. Specifically, the natural polymer having thermoreversible gelation characteristics provides fluidity of the solution when heated and forms a physical gelation structure upon cooling to maintain the dispersion state of the amorphous first hydrogel particles. In addition, the natural polymer may contribute to controlling the mechanical properties of the second matrix by forming a structure interpenetrating with the acrylamide-based polymer network.
[0099] If the content of the natural polymer is less than 5 parts by weight relative to 100 parts by weight of the second acrylamide-based monomer, the formation of a physical gelation structure may not be sufficient, and accordingly, the dispersion stability of the amorphous first hydrogel particles before curing may be reduced. On the other hand, if the content exceeds 50 parts by weight, the proportion of the physical cross-linking structure increases, which may increase the stiffness of the second matrix, and accordingly, it may be difficult to achieve the desired mechanical properties.
[0100] Meanwhile, the above-mentioned polyalkylene glycol-based polymer can control viscoelastic properties while distributed within the acrylamide-based polymer network and can contribute to improving the flexibility of the second matrix.
[0101] If the content of the polyalkylene glycol-based polymer is less than 10 parts by weight relative to 100 parts by weight of the second acrylamide-based monomer, the viscoelasticity control effect may not be sufficiently expressed, and accordingly, the flexibility of the second matrix may be limited. On the other hand, if the content exceeds 100 parts by weight, the relative proportion of the acrylamide-based polymer network decreases, and the mechanical strength and shape stability of the second matrix may be reduced.
[0102] Accordingly, by including 5 to 50 parts by weight of the natural polymer having the above-mentioned thermoreversible gelation characteristics and 10 to 100 parts by weight of the above-mentioned polyalkylene glycol-based polymer, a stable dispersion state of the amorphous first hydrogel particles can be maintained before curing, and mechanical properties in which the flexibility and shape stability of the second matrix are harmonized can be realized after curing.
[0103] In one embodiment of the present invention, the hydrogel composite composition may further include an aqueous solvent acting as a dispersion medium of the composition.
[0104] The above-mentioned aqueous solvent may include deionized water and may contain 70 to 95 weight percent of the above-mentioned aqueous solvent relative to the total weight of the composition to mimic the high water content characteristics of human tissue. Such water content can contribute to maintaining the diffusion of solutes and the mobility of polymer chains within the hydrogel, and can impart appropriate flexibility and water content characteristics to the cured body.
[0105] In addition, in one embodiment of the present invention, the hydrogel composite composition may further include an initiator and a crosslinking agent to induce a polymerization reaction of the acrylamide-based monomer.
[0106] Specifically, the initiator is capable of initiating the polymerization of an acrylamide-based monomer and may be selected from thermal initiators, redox initiators, or photoinitiators commonly used in the technical field to which the present invention belongs, and may include, for example, ammonium persulfate, potassium persulfate, and sodium persulfate. In addition, a reaction promoter such as tetramethylethylenediamine may be used together as needed.
[0107] Meanwhile, the above-mentioned crosslinking agent is capable of forming a crosslinked structure by connecting polymer chains formed during the polymerization process in three dimensions, and may include various crosslinking agents commonly used in the technical field to which the present invention belongs, and may include, for example, methylenebisacrylamide.
[0108] The types and content of the above initiator and crosslinking agent may affect the gelation time, crosslinking density, and mechanical properties of the final cured body of the composition, and accordingly, can be appropriately adjusted to achieve the desired physical properties.
[0109] In one embodiment of the present invention, the hydrogel composite composition may further include a coloring agent to mimic the visual characteristics of human tissue.
[0110] The above coloring agent may include water-soluble pigments or dyes, and may also include fluorescent materials as needed. Additionally, different coloring agents may be applied to the amorphous first hydrogel particles or the spherical particles inside them and to the second hydrogel matrix. For example, a yellow-based pigment may be applied to the amorphous first hydrogel particles, and a white or pink-based pigment may be applied to the second hydrogel matrix. Accordingly, discontinuous and continuous phases can be visually distinguished at the cross-section of the cured body, and visibility of the tissue structure can be improved.
[0111] In addition, in one embodiment of the present invention, the hydrogel composite composition may further include a preservative or an antimicrobial agent to improve storage stability.
[0112] Since the above hydrogel composite composition contains a large amount of moisture and natural polymers, deterioration may occur due to microbial growth. To prevent this, the composition may include sodium azide, parabens, chlorhexidine, or isothiazolinone-based preservatives or antimicrobial agents. The preservatives or antimicrobial agents can be dispersed within the composition to inhibit the growth of microorganisms, thereby improving the storage stability and durability of the composition.
[0114] Hydrogel composite structure
[0115] Another embodiment of the present invention provides a hydrogel composite structure comprising: a plurality of amorphous first hydrogel particles comprising a first matrix comprising a biocompatible polymer and a first acrylamide-based crosslinking polymer and a plurality of biocompatible hydrogels in the form of spherical particles dispersed in the first matrix; and a second hydrogel matrix comprising a second acrylamide-based crosslinking polymer, a natural polymer having thermoreversible gelation properties and a polyalkylene glycol-based polymer, and disposed between the plurality of amorphous first hydrogel particles, wherein the plurality of amorphous first hydrogel particles are discontinuous phases and are dispersed within the second hydrogel matrix which is a continuous phase.
[0116] The above hydrogel composite structure may be a three-dimensional structure formed by the aforementioned hydrogel composite composition undergoing a crosslinking and curing process within a molding mold of a predetermined shape. The above hydrogel composite structure may include a multiphase structure in which a plurality of components with different crosslinking structures, compositions, and mechanical properties are spatially arranged.
[0117] Specifically, the plurality of amorphous first hydrogel particles may form a discontinuous phase existing in a state where they are not continuously connected to one another, and the second hydrogel matrix may form a continuous phase that fills the space between the amorphous first hydrogel particles and is continuously formed throughout the structure. Due to this structure of coexistence of continuous and discontinuous phases, phase-specific interfaces may be formed inside the structure, and when an external force is applied, the interfaces may act as structural elements that influence the transmission and dispersion of stress.
[0118] In one embodiment of the present invention, the hydrogel composite structure may include a multilayer dispersion structure. For example, the spherical particle-shaped biocompatible hydrogel may be dispersed within the first matrix to form a first dispersion phase, and the amorphous first hydrogel particles containing the first dispersion phase may be dispersed within the second hydrogel matrix to form a second dispersion phase.
[0119] Due to such a structure, the structure may have a form in which a microscopic dispersion structure and a macroscopic dispersion structure are superimposed, and when external stress is applied, the stress may be distributed along the boundary surface of the second dispersion phase and the boundary surface of the first dispersion phase. In addition, the multi-layered dispersion structure may provide structural features that diversify the stress transfer path within the structure.
[0120] In one embodiment of the present invention, the hydrogel composite structure may include different crosslinking structures. For example, the spherical particle-shaped biocompatible hydrogel may include an ionic crosslinking structure formed by a multivalent cation, and the first matrix and the second hydrogel matrix may each include a crosslinking polymer structure formed by the polymerization of an acrylamide-based monomer.
[0121] As such, since ion-crosslinked regions and crosslinked polymer regions coexist within the structure, the hydrogel composite structure may have a structure containing a plurality of crosslinked domains. Additionally, the spherical particle-shaped biocompatible hydrogel may act as a reinforcing phase dispersed within the first matrix, and the first matrix and the second hydrogel matrix may form a continuous polymer network surrounding the reinforcing phase.
[0122] In one embodiment of the present invention, the plurality of amorphous first hydrogel particles may include a fracture surface formed by a fragmentation process. The fracture surface may include surface irregularities of an irregular shape and may have a structure in which the spherical particle-shaped biocompatible hydrogel and the first matrix are exposed to the outside together in at least some areas.
[0123] Due to the exposure structure described above, the surface of the amorphous first hydrogel particle may include multiple regions with different compositions and structures. For example, some regions may be regions where the surface of the spherical particle is exposed, and other regions may be regions where the fracture surface of the first matrix is exposed. Additionally, the first matrix exposed on the fracture surface may come into direct contact with the second hydrogel matrix to form an interface, and at the interface, physical entanglement between polymer chains or an interfacial diffusion structure may be formed.
[0124] These structural features can contribute to suppressing interfacial delamination between particles and the matrix, which may occur when the monomer content in the matrix is reduced to achieve ultra-low elasticity similar to biological soft tissue. Specifically, a second hydrogel matrix, which is a continuous phase, penetrates the fracture surface formed through the fragmentation process to form a coating structure, thereby increasing the bonding area between the discontinuous phase and the continuous phase and improving interfacial bonding strength.
[0125] FIGS. 10 and 11 are schematic diagrams and photographs comparing the interfacial delamination phenomenon that may occur when the monomer content is reduced to achieve ultra-low elasticity at the level of biological soft tissue, and the structural changes according to the multi-stage control process (fragmentation and multiple immersion) of the present invention to improve this.
[0126] Referring to FIG. 10, a structure is shown in which a conventional single bulk molding process is applied with reduced monomer content. In this case, as the mixed solution containing the immersed beads is cured in a single block form, chemical and physical interactions between the spherical particles and the matrix are not sufficiently formed, which may result in a decrease in interfacial bonding strength. Consequently, as indicated by the right photograph of FIG. 10 and the red circle, an interfacial delamination defect may occur in which the interface between the particles and the matrix separates when external forces, such as manual manipulation by the operator or compression and bending by surgical instruments, are applied.
[0127] On the other hand, FIG. 11 illustrates the manufacturing process and structure of a composite structure in which the primary curing, fragmentation, and secondary immersion processes according to the present invention are sequentially applied. By physically fragmenting the precursor after the primary curing is completed, particles with a structure in which a first matrix surrounds the bead are formed, and then the particles are cured by secondary immersion in a second matrix solution, thereby allowing the second matrix components to penetrate into the surface and fracture surface exposed during the fragmentation process. Accordingly, a composite structure with improved interfacial bonding between the particles and the matrix is formed.
[0128] Furthermore, in one embodiment of the present invention, the hydrogel composite structure may include a multilayer structure in which the distribution density or content of amorphous first hydrogel particles is formed differently along the thickness direction of the structure.
[0129] For example, a first region of the structure may include a dense layer with a relatively high volume fraction of the amorphous first hydrogel particles, and a second region adjacent thereto may include a continuous phase dominant layer with a relatively high volume fraction of the second hydrogel matrix. Additionally, each region may form a density gradient that changes stepwise or continuously.
[0130] Such a multilayer structure can provide different compositional distributions and microstructures depending on the location of the structure, and accordingly, the distribution of physical properties within the structure can be controlled. In addition, the multilayer structure can provide structural characteristics that are distinguishable from a homogeneous structure formed of a single composition.
[0131] In one embodiment of the present invention, the hydrogel composite structure can be applied to a surgical simulation model for surgical procedure training, and in particular, can be utilized as a tissue model to simulate the incision and dissection behavior of adipose tissue surrounding human organs.
[0132] In one embodiment, the hydrogel composite structure may be applied as a structure simulating perirenal fat in a partial nephrectomy training simulator. In this case, a kidney, a ureter, or an artificial organ structure simulating them may be placed inside or on one surface of the hydrogel composite structure. The second hydrogel matrix may be placed along the surface shape of the artificial organ structure in an uncured state and then cured, thereby forming an interface structure that is in close contact between the organ structure and the fat tissue simulating structure.
[0133] In addition, the hydrogel composite structure may further include a hollow tubular structure for mimicking a blood vessel. The tubular structure may include one or more tubes mimicking an artery or a vein and may be embedded at a predetermined location during the formation process of the structure.
[0134] For example, when the hydrogel composite structure is formed by stacking multiple layers, it can be manufactured by forming a first layer, placing a first tubular structure thereon, forming a second layer on top of it, placing a second tubular structure thereon, and then stacking additional layers. Accordingly, a three-dimensional arrangement structure reflecting the actual anatomical structure can be realized, and the operator can perform training to expose the tubular structure placed inside by stepwise incising or dissecting the fat tissue mimic.
[0135] In addition, due to the structural features of the hydrogel composite structure comprising a second hydrogel matrix in a continuous phase and a first hydrogel particle in a discontinuous phase, local deformation or fracture may occur along the interface between the continuous phase and the discontinuous phase during the cutting or peeling process. Accordingly, it can be utilized to simulate the behavior of actual biological tissues in which adipose tissue and connective tissue coexist.
[0136] Meanwhile, the above hydrogel composite structure may have a certain level of flexibility and shape stability through a composite network structure comprising a polyalkylene glycol-based polymer, a crosslinking polymer, and a biocompatible polymer. In addition, it can be applied to repetitive simulations while maintaining the shape of the structure even when external forces, such as cutting or compression, are applied.
[0137] In particular, the polyalkylene glycol-based polymer included in the second hydrogel matrix can act as a plasticizing component to suppress stickiness that may occur on the surface as the monomer content of the structure decreases. Accordingly, the hydrogel composite structure can be used in simulation environments where not only general surgical instruments such as scalpels, forceps, and sutures, but also energy-using surgical equipment such as ultrasonic cutters and electrocauteries are applied. Furthermore, by suppressing adhesion phenomena on the surface of the structure when these surgical instruments are applied, it can provide tactile feedback and maneuverability similar to actual biological tissue, and can be utilized as a tissue mimic for training various surgical skills such as incision, dissection, exposure, and suturing.
[0139] Method for manufacturing a hydrogel composite structure
[0140] Another aspect of the present invention provides a method for manufacturing the aforementioned hydrogel composite structure.
[0141] The manufacturing method according to the present invention is characterized by including a plurality of immersion and fragmentation processes to spatially separate and form chemical and physical bonding networks, unlike a simple batch mixing process, and to improve interfacial bonding characteristics between different phases.
[0142] Specifically, a method for manufacturing a hydrogel composite structure according to one embodiment of the present invention may include: (a) a step of manufacturing and dehydrating a biocompatible hydrogel in the form of spherical particles; (b) a step of forming a primary hydrogel precursor using a curing agent after first immersing the spherical particles in a main solution of a first matrix; (c) a step of fragmenting the primary hydrogel precursor to form amorphous first hydrogel particles and secondarily immersing them in a main solution of a second matrix; and (d) a step of mixing the secondarily immersed amorphous first hydrogel particles with the second matrix solution and finally curing to form a hydrogel composite structure.
[0144] (a) Step for manufacturing biocompatible hydrogel in the form of spherical particles
[0145] This step may be a process for forming an internal core (first dispersion phase) that performs the role of stress distribution and mechanical support within the composite structure.
[0146] First, a single liquid hydrogel precursor mixed solution can be prepared by mixing an ion-crosslinkable natural polymer such as alginate, a thermoreversible natural polymer such as agarose, and an acrylamide-based monomer in an aqueous solvent and heating. In particular, by including the thermoreversible natural polymer and the acrylamide-based monomer together in the mixed solution, the leakage of unreacted liquid components inside the particles can be suppressed even when producing relatively large spherical particles of 2 to 5 mm, thereby maintaining the shape stability of the spherical shape. Subsequently, an interfacial ion crosslinking reaction can be induced by dropwise introducing the mixed solution at a constant rate into an aqueous solution of a polyvalent cation crosslinking agent (e.g., an aqueous calcium chloride solution) with a concentration of 0.05 to 0.2 M.
[0147] At this time, it may be desirable to maintain the mixed solution heated so that its internal temperature reaches a range of 60 to 65 ℃ before dropping. If the temperature of the solution drops below 60 ℃, premature gelation may occur inside the dropping nozzle due to the properties of the thermoreversible natural polymer, and consequently, it may become difficult to form stable droplets. On the other hand, if the temperature of the solution exceeds 65 ℃, the surface tension decreases, and the sphericity of the particles may decrease during contact with the aqueous crosslinking agent solution.
[0148] In addition, the distance between the drop nozzle and the surface of the crosslinking agent aqueous solution can be controlled to a range of 1 to 5 cm, and the crosslinking agent aqueous solution can be stirred at a speed of 100 to 200 rpm. Through this, it is possible to form spherical particles having a relatively uniform size and shape.
[0149] The spherical particles that have completed crosslinking may undergo a natural filtration and dehydration process on a sieve for a certain period of time (e.g., 20 to 40 minutes). During this process, by periodically mixing the particles and removing the residual crosslinking agent solution that settles at the bottom, the amount of polyvalent cations remaining on the particle surface can be reduced. This dehydration process can help facilitate the diffusion of matrix components and interfacial interactions during the subsequent immersion step.
[0151] (b) Primary soaking and primary hydrogel precursor formation step
[0152] This step may be a process for enhancing interfacial interactions between the spherical particles and the first matrix surrounding them, and for forming a primary hydrogel precursor that serves as the basis for a subsequent fragmentation process.
[0153] First, a first matrix main solution that does not contain an initiator and a crosslinking agent is prepared, and the dehydrated spherical particles are added to perform a first immersion for 20 to 40 minutes while heating and stirring in a range of 70 to 80°C (e.g., about 75°C). At this time, the first matrix main solution may be used in a weight ratio of 1.0 to 2.0 times, preferably about 1.5 times, relative to the weight of the spherical particles.
[0154] During the above immersion process, moisture present inside the spherical particles may move to the outside, and consequently, monomer and polymer components contained in the first matrix subject solution may penetrate into the pores inside the particles. As a result, an interfacial interaction region may be formed between the spherical particles and the first matrix, which can contribute to improving the bonding characteristics between the two components during the subsequent curing process. In particular, the interfacial bonding strength can be enhanced by the acrylamide-based monomer component pre-containing inside the particles forming a mutual polymerization network with the monomers of the penetrated first matrix.
[0155] After immersion is complete, a filtration process can be performed to remove any remaining main solution that has not been absorbed by the particles.
[0156] Subsequently, a base solution can be prepared by mixing a new first matrix main solution heated to a range of 75 to 85 ℃ (e.g., about 80 ℃) and a curing agent solution in a weight ratio of about 4:1. The heating process may be performed for the purpose of ensuring uniform mixing and reactivity of the solution in the subsequent curing step.
[0157] The spherical particles that have undergone the first immersion can be mixed in a ratio of 50 to 300 parts by weight, for example, about 120 parts by weight, with respect to 100 parts by weight of the prepared base solution. Subsequently, by adding an accelerator and injecting into a mold to cure at room temperature, a primary hydrogel precursor in the form of a single block, in which the spherical particles are dispersed within a first matrix, can be formed.
[0158] Meanwhile, a separate washing process can be omitted during the process of separating the above precursor from the mold. If the washing process is not performed in this way, the loss of the interfacial interaction region formed between the spherical particles and the first matrix can be minimized, and this can help secure superior interfacial bonding characteristics in subsequent processes.
[0160] (c) Fragmentation and secondary soaking stage
[0161] This step may be a process for converting the primary hydrogel precursor into a plurality of amorphous first hydrogel particles and improving interfacial bonding characteristics with a subsequent continuous phase matrix.
[0162] When the monomer content in the matrix is reduced to achieve very low elasticity (ultra-low elasticity) of biological soft tissue, performing single bulk curing in the primary hydrogel precursor state may result in a decrease in interfacial bonding strength between the spherical particles and the matrix, which can cause interfacial delamination (see Fig. 10). Therefore, to suppress this interfacial delamination, it is desirable to perform a fragmentation process and a secondary multiple immersion process (see Fig. 11).
[0163] First, the above primary hydrogel precursor can be mechanically fragmented using a grinder or the like. Accordingly, a plurality of amorphous primary hydrogel particles having an irregular shape and an uneven structure can be formed.
[0164] In the fracture surface formed during the above fragmentation process, not only the cut surface of the first matrix but also a portion of the spherical particles dispersed inside may be exposed. Accordingly, a heterogeneous interface in which regions with different compositions and structures are mixed may be formed on the surface of the amorphous first hydrogel particles.
[0165] Afterwards, a second immersion process using a second matrix subject solution can be performed on the above-mentioned amorphous first hydrogel particles.
[0166] Specifically, a second matrix main solution corresponding to 1.0 to 2.0 times, for example, about 1.5 times, the weight of the amorphous first hydrogel particles may be added, and immersion may be performed for 5 to 15 minutes in a range of 70 to 80°C (e.g., about 75°C).
[0167] During the above second immersion process, monomer and polymer components of the second matrix can penetrate into the cross-section and micropores exposed during the fragmentation process. This can induce the coating of the second matrix components on the surface of the amorphous first hydrogel particles, thereby improving the interfacial affinity between the amorphous first hydrogel particles and the subsequent continuous phase matrix, and contributing to the improvement of interfacial bonding characteristics after final curing.
[0168] After the immersion is complete, a filtration process can be performed to remove excess main solution, after which subsequent processes can be carried out.
[0170] (d) Mixing of hydrogel composite composition and molding of final structure
[0171] This step may be a process for dispersing the amorphous first hydrogel particles within a second hydrogel matrix and forming a final hydrogel composite structure.
[0172] First, a second matrix main solution containing a polyalkylene glycol-based polymer acting as a plasticizing component can be heated to a range of 75 to 85°C (e.g., about 80°C) and then mixed with a curing agent solution in a weight ratio of about 4:1. By adding the polyalkylene glycol-based polymer, stickiness that may occur on the surface of the structure due to a decrease in monomer content can be suppressed.
[0173] The above formulation ratio is intended to control the crosslinking density and network structure of the final structure, and can be utilized to control the elastic modulus, deformation compliance, and mechanical properties of the final cured body within an appropriate range.
[0174] Afterwards, the amorphous first hydrogel particles, which have undergone secondary immersion, can be added in a ratio of 50 to 200 parts by weight, for example, about 100 parts by weight, to 100 parts by weight of the second matrix mixed solution.
[0175] Afterwards, an accelerator is added and stirred to form a composite composition in which discontinuous phase particles are uniformly dispersed within a continuous phase matrix.
[0176] The mixed composite composition can be injected into a mold of a desired shape. At this time, additional processes to remove air bubbles or adjust the particle distribution can be performed.
[0177] The injected composition can be formed into a final structure through a cooling and curing process.
[0178] Specifically, as the temperature decreases, the thermoreversible natural polymer contained in the second matrix can preferentially form a physical gel. Accordingly, the spatial distribution state of the amorphous first hydrogel particles can be maintained, and the sedimentation or aggregation of the particles can be suppressed.
[0179] Subsequently, a chemical crosslinking reaction of the acrylamide-based monomer can proceed by an initiator and an accelerator, thereby forming a continuous phase matrix and producing a hydrogel composite structure in which the discontinuous phase is stably fixed.
[0181] Selective Multi-layer Molding Process
[0182] In one embodiment, step (d) may further include a stacking process for forming a multi-layered structure.
[0183] For example, a mixed solution corresponding to the first layer can be injected into a mold and cured, and then a blood vessel-mimicking tube can be placed on top thereof. Subsequently, a structure having multiple layers can be formed by sequentially injecting and curing the mixed solutions of the second and third layers.
[0184] In addition, between each lamination step, a process for removing uncured solution present on the surface of the preceding layer may be included.
[0185] By removing the aforementioned uncured solution, direct contact between the subsequent layer and the preceding layer can be enabled, thereby improving interlayer bonding characteristics. Additionally, this can contribute to reducing the possibility of interlayer delamination in the final structure and enhancing structural stability.
[0186] Furthermore, through the above-mentioned stacking process, blood vessel mimics, organ mimics, or other functional structures can be placed at desired locations within the structure, thereby enabling the manufacture of a surgical simulation model having a shape similar to an actual anatomical structure.
[0188] Specific embodiments of the present invention are presented below. However, the embodiments described below are merely for the purpose of specifically illustrating or explaining the present invention and do not limit the present invention. Furthermore, details not described herein can be sufficiently technically inferred by a person skilled in the art, so their description is omitted.
[0190] Example 1: Preparation of hydrogel composite composition and structure
[0191] (1) Preparation of spherical particle-shaped biocompatible hydrogels (beads)
[0192] According to the composition of [Table 1] below, a bead precursor solution was prepared by adding alginate, agarose, and acrylamide powder to deionized water and stirring at 75°C to completely dissolve them. Subsequently, yellow coloring agents, aureolin and Indian yellow, were added to the bead precursor solution and mixed uniformly.
[0193] The above bead precursor solution was dropped into a 0.1 M calcium chloride (CaCl2) aqueous solution being stirred at 180 to 200 rpm while maintaining the temperature at 60 ℃ (see Fig. 2 (a) and (b)). At this time, the distance between the dropping nozzle and the surface of the calcium chloride aqueous solution was maintained at 5 cm or less. The dropped droplets were ionically cross-linked within the calcium chloride aqueous solution to form spherical particles.
[0194] The formed spherical particles were collected using a sieve and filtered, and dehydrated by leaving them for about 30 minutes to remove the eluent (see Fig. 2 (c)). As a result, spherical particles with an average diameter of 3.5 ± 0.5 mm were obtained (see Fig. 2 (d)).
[0195] Ingredient name Mixing amount (g) DI water 100 Acrylamide 5 Alginate 0.5 Agarose 0.5 Aureolin 0.05 Indian yellow 0.05
[0197] (2) Soaking 1 of the matrix and formation of the primary hydrogel precursor (primary fat)
[0198] After heating the solution prepared according to the first matrix base composition of [Table 2] below to 75°C, a base solution with a weight of 1.5 times the spherical particles obtained in (1) was added, and a first soaking was performed for 30 minutes (see Fig. 3 (a)). After the soaking was completed, the unabsorbed residual base solution was removed by filtration (see Figs. 3 (b) and (c)).
[0199] Subsequently, a first matrix mixed base solution was prepared by mixing a first matrix main solution heated to 80 ℃ and a hardener solution in a weight ratio of 4:1. 45 g of the first immersed spherical particles were added to 40 g of the mixed base solution and mixed uniformly (main:hardener:bead = 32:8:45), followed by the addition of 30 µl of TEMED and injection into a mold (see Fig. 4 (a)).
[0200] The injected mixture was cured at room temperature to produce a primary hydrogel precursor in the form of a single block, in which spherical particles of biocompatible hydrogel were dispersed within a first matrix (see Fig. 4 (b)). The prepared primary hydrogel precursor was used as an intermediate to form amorphous first hydrogel particles through a subsequent fragmentation process.
[0201] division Ingredient name Mixing amount (g) Topic (Base) DI water 80 Acrylamide 12 Agarose 0.025 NaCl 0.8 PEG 20000 2.2 Paraben 0.3 Aureolin 0.7 Indian yellow 0.6 Curing agent DI water 20 APS 0.2448 MBA 0.048
[0203] (3) Fragmentation and secondary soaking (Soaking 2)
[0204] A plurality of amorphous first hydrogel particles were prepared by physically fragmenting the first hydrogel precursor prepared in (2) above using a grinder.
[0205] Subsequently, a second matrix main solution at a weight of 1.5 times the amorphous first hydrogel particles was added, and a second soaking was performed at 75°C for 10 minutes. Through the second soaking process, the second matrix component was allowed to penetrate the particle surface and fracture surface exposed during the fragmentation process, and after the soaking was completed, the remaining main solution was removed by filtration.
[0207] (4) Mixing of final composite composition and molding of structure
[0208] A second matrix mixed solution was prepared by mixing 20 g of a second matrix main solution heated to 80 ℃ and 5 g of a curing agent solution in a weight ratio of 4:1.
[0209] Subsequently, 25 g of the second immersed amorphous first hydrogel particles were added to 25 g of the second matrix mixed solution and mixed in a weight ratio of 1:1, and 30 µl of TEMED was added and stirred rapidly.
[0210] After injecting the mixed composition into a mold, the final hydrogel composite structure was prepared by curing it at room temperature for about 5 minutes (see Fig. 4 (c)). The prepared hydrogel composite structure formed a dual-phase structure in which amorphous first hydrogel particles were dispersed as a discontinuous phase within a second hydrogel matrix, and was subsequently used as a test specimen for evaluating physical properties and cutting and peeling characteristics.
[0212] Example 2: Preparation of a partial nephrectomy model having a multi-layered distributed structure
[0213] A hydrogel composite composition was prepared in the same manner as in Example 1, but multi-layered molding in the thickness direction was performed according to the mixing ratios in [Table 3] below within a molding mold in which kidney and ureter mimics were placed (see Fig. 5).
[0214] Specifically, after injecting the hydrogel composite composition for the 1-layer into the mold (see FIG. 6 (1)), the elongation model was slightly lifted so that the composition was uniformly filled into the lower space of the elongation model (see FIG. 6 (2)). Then, the composition was cured at room temperature to form the first layer (see FIG. 6 (3)).
[0215] After the curing of the first layer was completed, any uncured solution remaining on the surface was removed using a wet wipe, and a vascular tube mimicking a vein was placed on top of it (see Fig. 7 (4)). Then, a hydrogel composite composition for a 2-layer was injected and cured at room temperature to form the second layer (see Fig. 7 (5)).
[0216] After removing any uncured solution remaining on the surface even after the second layer was cured, a vascular tube mimicking an artery was placed at a predetermined location (see Fig. 7 (6)). Then, a hydrogel composite composition for a 3-layer was injected to ensure that the extension mimic and the vascular tube were sufficiently embedded, and then cured at room temperature to form a third layer (see Fig. 7 (7)).
[0217] Finally, a multilayer hydrogel composite structure with three layers stacked sequentially was manufactured, and the hydrogel composite structure was used as a surgical simulation model for partial nephrectomy training with a kidney mimic, a ureter mimic, and a blood vessel mimic tube embedded inside.
[0218] Layer Matrix topic (g) Matrix hardener (g) Secondary immersion fragmented fat (g) TEMED (µl) 1-Layer 32 8 40 30 2-Layer 20 5 25 20 3-Layer 20 5 25 20
[0220] Comparative Example 1: Preparation of a single matrix-based adipose tissue-like structure
[0221] (1) Preparation of spherical particle-shaped biocompatible hydrogels (beads)
[0222] An aqueous alginate solution was prepared as a biocompatible hydrogel solution by dissolving 0.75 g of alginate containing carboxyl groups in 100 g of deionized water.
[0223] An aqueous calcium chloride solution was prepared by dissolving 1.11 g of calcium chloride (CaCl2) in 100 g of deionized water, and the aqueous alginate solution was added dropwise to the aqueous calcium chloride solution to prepare spherical particle-shaped alginate.
[0224] The average diameter (D50) of the individual particles of the manufactured multiple spherical alginate particles is 1.0 mm, and the multiple alginate particles are aggregated to form granules. The granular alginate particles were washed using deionized water.
[0226] (2) Immersion in network precursor solution
[0227] A network precursor solution was prepared by dissolving 28.2 g of acrylamide, 0.034 g of N,N'-methylenebisacrylamide (MBA) as a crosslinking agent, and 0.095 g of ammonium persulfate (APS) as a thermosetting agent in 100 g of deionized water.
[0228] The granular particulate alginate prepared in (1) above was added to the above network precursor solution and immersed for 180 minutes.
[0230] (3) Mixing of network solution and preparation of final structure
[0231] A network solution not containing polyethylene glycol (PEG), a softening agent, was prepared by dissolving 28.2 g of acrylamide, 0.034 g of N,N'-methylenebisacrylamide (MBA), 0.095 g of ammonium persulfate (APS), 1.28 g of alginate as a biocompatible polymer, and 18.6 µl of tetramethylethylenediamine (TEMED) in 100 g of deionized water.
[0232] After recovering the granular particulate alginate immersed in (2) above, 130 g was added to the network solution. Then, by curing it in an oven at 60°C for 60 minutes, a hydrogel structure in which spherical particulate hydrogels are encapsulated within a single matrix was prepared.
[0233] In Comparative Example 1, the physical properties were evaluated using a single block-shaped structure that had been cured as the final test specimen, without performing a separate physical fragmentation process for spherical particles or a re-immersion process for fragmented particles.
[0235] Comparative Example 2: Preparation of a live control (actual bovine adipose tissue) specimen
[0236] Bovine adipose tissue specimens were prepared as a control group to compare the viscoelastic properties of the hydrogel structures prepared in the examples and comparative examples with actual biological tissues.
[0237] Specifically, the subcutaneous fat layer was separated from the bovine tissue immediately after slaughter and transported to the laboratory while immersed in phosphate-buffered saline (PBS) maintained at 4°C to prevent tissue denaturation and moisture loss.
[0238] Subsequently, visible blood vessels, muscle fibers, and connective tissues were removed from the collected adipose tissue to select only the adipose tissue. The selected adipose tissue was punched to a diameter of 50 mm using a biopsy punch for biological tissue, and then cut into disc shapes approximately 2 mm thick to prepare a biological control specimen.
[0239] The prepared specimens were sealed with gauze soaked in PBS solution and stored at room temperature to prevent changes in physical properties due to moisture evaporation, and were subsequently prepared for use in rheological property evaluation to compare viscoelastic properties with the examples and comparative examples.
[0240] Experimental Example 1: Evaluation of Dynamic Rheological Properties (Viscoelasticity) of Hydrogel Composite Structure
[0241] A dynamic rheology test using a rheometer was performed to determine whether the hydrogel composite structure prepared according to Example 1 of the present invention mimics the mechanical properties of actual biological adipose tissue and to quantitatively evaluate the effect of reducing viscoelasticity compared to Comparative Example 1.
[0242] Specifically, the respective structures prepared in Example 1 and Comparative Example 1, and the actual bovine fat tissue prepared in Comparative Example 2, were prepared as disc-shaped test specimens with a diameter of 50 mm and a thickness of 2 mm. For viscoelasticity measurements, a rotary rheometer equipped with a parallel plate geometry with a diameter of 50 mm was used, and the measurement interval between the upper and lower plates was set to 2 mm. The measurement temperature was maintained at 25 ℃, and subsequently, an oscillatory time sweep test was performed on each specimen under conditions of a shear strain of 0.1% within the Linear Viscoelastic Region (LVR) and a vibration frequency of 1 Hz. During the test, the storage modulus (G′) and loss modulus (G″) were measured to evaluate the stability of the viscoelastic properties over time, and the results are shown in Fig. 8.
[0243] Referring to Fig. 8, Comparative Example 1, a single matrix structure using a high content of acrylamide monomer and without applying a softening agent or fragmentation process, was measured to have a storage modulus of approximately 20,000 Pa or higher in the linear viscoelastic region, confirming that it exhibits higher stiffness compared to actual biological adipose tissue. On the other hand, the actual bovine adipose tissue of Comparative Example 2, which serves as a biological control, was measured to have a storage modulus of several hundred Pa, confirming that adipose tissue is a viscoelastic material with low stiffness. Meanwhile, the hydrogel composite structure according to Example 1 of the present invention was measured to have a storage modulus in the range of approximately 330 to 415 Pa in the linear viscoelastic region. This value represents a significantly reduced storage modulus compared to Comparative Example 1, confirming that it exhibits mechanical behavior similar to that of actual bovine adipose tissue.
[0244] In addition, according to a recently reported document (Journal of Biomechanics 177 (2024) 112416), the storage modulus of human orbital fat was reported to be 737 Pa (margin of error 310 Pa), and the storage modulus of Example 1 showed a level similar to the range of mechanical properties of human adipose tissue reported in the aforementioned document. Therefore, the present invention was able to effectively reduce the storage modulus compared to a conventional single matrix structure by introducing a discontinuous dual-phase structure through the addition of a softening agent within the matrix and fragmentation, thereby reducing the monomer content to mimic the soft properties of actual adipose tissue while addressing the interfacial delamination between particles and the matrix and the resulting surface stickiness issues. It was also confirmed that mechanical properties similar to actual biological adipose tissue could be achieved, as shown in Figure 8.
[0245] Although preferred embodiments of the present invention have been described in detail above, the scope of the present invention is not limited thereto, and various modifications and improvements by those skilled in the art using the basic concept of the present invention as defined in the following claims also fall within the scope of the present invention.
Claims
Claim 1 A hydrogel composite composition comprising: a plurality of amorphous first hydrogel particles comprising a first matrix comprising a biocompatible polymer and a first acrylamide-based crosslinking polymer, and a plurality of biocompatible hydrogels in the form of spherical particles dispersed in the first matrix; and a second matrix solution comprising a second acrylamide-based monomer, a natural polymer having thermoreversible gelation properties, and a polyalkylene glycol-based polymer, disposed between the plurality of amorphous first hydrogel particles; wherein the plurality of amorphous first hydrogel particles are dispersed in a discontinuous phase within the second matrix solution. Claim 2 A hydrogel composite composition according to claim 1, wherein the spherical particle-shaped biocompatible hydrogel is formed by ionically crosslinking one or more natural polymers selected from the group consisting of alginate, chitosan, hyaluronic acid, pectin, and carrageenan by polyvalent cations. Claim 3 A hydrogel composite composition according to claim 1, wherein the first monomer for forming the first acrylamide-based crosslinking polymer and the second acrylamide-based monomer each independently comprise one or more selected from the group consisting of acrylamide, methacrylamide, N-isopropylacrylamide, N,N-dimethylacrylamide, and N-hydroxyethyl acrylamide. Claim 4 A hydrogel composite composition according to claim 1, wherein the biocompatible polymer included in the first matrix and the natural polymer having thermoreversible gelling properties included in the second matrix solution each independently comprise one or more selected from the group consisting of gelatin, agarose, collagen, elastin, and fibrin. Claim 5 A hydrogel composite composition according to claim 1, wherein the polyalkylene glycol-based polymer comprises one or more selected from the group consisting of polyethylene glycol (PEG), polypropylene glycol (PPG), and polyethylene glycol-polypropylene glycol copolymer (PEG-PPG copolymer). Claim 6 A hydrogel composite composition according to claim 1, wherein the amorphous first hydrogel particles comprise fragments formed by physically fragmenting a primary hydrogel precursor in which the spherical particle-shaped biocompatible hydrogel is crosslinked in a state dispersed within the first matrix. Claim 7 A hydrogel composite composition according to claim 1, wherein the hydrogel composite composition comprises 50 to 200 parts by weight of the second matrix solution per 100 parts by weight of the amorphous first hydrogel particles. Claim 8 A hydrogel composite composition according to claim 1, wherein the amorphous first hydrogel particles are dispersed in an amount of 50 to 300 parts by weight of the spherical particle-shaped biocompatible hydrogel with respect to 100 parts by weight of the first matrix. Claim 9 A hydrogel composite composition according to claim 1, wherein the second matrix solution comprises 5 to 50 parts by weight of a natural polymer having thermoreversible gelling properties and 10 to 100 parts by weight of a polyalkylene glycol-based polymer, based on 100 parts by weight of the second acrylamide-based monomer. Claim 10 A hydrogel composite composition according to claim 1, characterized in that the weight-average molecular weight (Mw) of the polyalkylene glycol-based polymer is 10,000 to 40,000 g / mol. Claim 11 A hydrogel composite structure comprising: a plurality of amorphous first hydrogel particles comprising a first matrix comprising a biocompatible polymer and a first acrylamide-based crosslinking polymer, and a plurality of biocompatible hydrogels in the form of spherical particles dispersed in the first matrix; and a second hydrogel matrix comprising a second acrylamide-based crosslinking polymer, a natural polymer having thermoreversible gelation properties, and a polyalkylene glycol-based polymer, and disposed between the plurality of amorphous first hydrogel particles; wherein the plurality of amorphous first hydrogel particles are discontinuous phases and are dispersed within the second hydrogel matrix which is a continuous phase. Claim 12 A hydrogel composite structure according to claim 11, characterized in that the biocompatible hydrogel in the form of spherical particles is dispersed within the first matrix to form a first dispersed phase, and the amorphous first hydrogel particles containing the first dispersed phase are dispersed within the second hydrogel matrix to form a second dispersed phase. Claim 13 A hydrogel composite structure according to claim 11, wherein the spherical particle-shaped biocompatible hydrogel comprises an ionic crosslinking structure formed by a multivalent cation, and the first matrix and the second hydrogel matrix each comprise a crosslinking structure formed by an acrylamide-based crosslinking polymer. Claim 14 A hydrogel composite structure according to claim 11, wherein the plurality of amorphous first hydrogel particles include a fracture surface formed by fragmentation, and at least a portion of the fracture surface includes a region in which the spherical particle-shaped biocompatible hydrogel and the first matrix are exposed to the outside together and come into contact with the second hydrogel matrix.
Citation Information
Patent Citations
Alginate hydrogel composition
JP7423677B2
Preparation of non-covalent interpenetrating network hydrogel and method for manufacturing product of it
KR1020230081755A
Composition for forming adipose tissue-like structure and method for manufacturing adipose tissue-like structure
KR102844193B1
Hemostatic paste and uses thereof
US20230001048A1
